Orphan designation: N-Hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide Treatment of schwannoma, 06/06/2012 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 21 August 2026 - 13:26

Orphan designation: N-Hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide Treatment of schwannoma, 06/06/2012 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-12-997

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters